International Immunology, Vol. 11, No. 1, 11-20,
January 1999
© 1999 Japanese Society for Immunology
Minimal cross-linking and epitope requirements for CD40-dependent suppression of apoptosis contrast with those for promotion of the cell cycle and homotypic adhesions in human B cells
Division of Immunity and Infection, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
1 Immunex Corp., Seattle, WA 98101, USA
2 Department of Molecular Immunology, Research Institute for Microbial Diseases, Osaka University, Osaka 565, Japan
3 Mabtech AB, SE-131 40 Nacka, Sweden
Correspondence to: J. Gordon
Eight different CD40 mAb shared with soluble trimeric CD40 ligand (sCD40LT) the capacity to rescue germinal center (GC) B cells from spontaneous apoptosis and to suppress antigen receptor-driven apoptosis in group I Burkitt's lymphoma cells. Three mAb (G28-5, M2 and M3) mimicked sCD40LT in its ability to promote strong homotypic adhesion in resting B cells, whereas others (EA5, BL-OGY/C4 and 5C3) failed to stimulate strong clustering. Binding studies revealed that only those mAb that promoted strong B cell clustering bound at, or near to, the CD40L binding site. While all eight mAb and sCD40LT were capable of synergizing with IL-4 or phorbol ester for promoting DNA synthesis in resting B cells, co-stimulus-independent activation of the cells into cycle through CD40 related directly to the extent of receptor cross-linking. Thus, mAb which bound outside the CD40L binding site synergized with sCD40LT for promoting DNA synthesis; maximal levels of stimulation were achieved by presenting any of the mAb on CD32 transfectants in the absence of sCD40LT or by cross-linking bound sCD40LT with a second antibody. Monomeric sCD40L, which was able to promote rescue of GC B cells from apoptosis, was unable to drive resting B cells into cycle. These studies demonstrate that CD40-dependent rescue of human B cells from apoptosis requires minimal cross-linking and is essentially epitope independent, whereas the requirements for promoting cell cycle progression and homotypic adhesion are more stringent. Possible mechanisms underlying these differences and their physiological significance are discussed.
Keywords: B cell, receptor, CD40 ligand, germinal center, signalling
4 Present address: Department of Medicine and Pharmacology, University of Sheffield Medical School, Sheffield SI0 2JF, UK
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C.-L. Law, K. A. Gordon, J. Collier, K. Klussman, J. A. McEarchern, C. G. Cerveny, B. J. Mixan, W. P. Lee, Z. Lin, P. Valdez, et al. Preclinical Antilymphoma Activity of a Humanized Anti-CD40 Monoclonal Antibody, SGN-40 Cancer Res., September 15, 2005; 65(18): 8331 - 8338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wulff, H.-G. Knaus, M. Pennington, and K. G. Chandy K+ Channel Expression during B Cell Differentiation: Implications for Immunomodulation and Autoimmunity J. Immunol., July 15, 2004; 173(2): 776 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Reyes-Moreno, J. Girouard, R. Lapointe, A. Darveau, and W. Mourad CD40/CD40 Homodimers Are Required for CD40-induced Phosphatidylinositol 3-Kinase-dependent Expression of B7.2 by Human B Lymphocytes J. Biol. Chem., February 27, 2004; 279(9): 7799 - 7806. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Jullien, R. Q. Cron, K. Dabbagh, A. Cleary, L. Chen, P. Tran, P. Stepick-Biek, and D. B. Lewis Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation Int. Immunol., December 1, 2003; 15(12): 1461 - 1472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Krippner-Heidenreich, F. Tubing, S. Bryde, S. Willi, G. Zimmermann, and P. Scheurich Control of Receptor-induced Signaling Complex Formation by the Kinetics of Ligand/Receptor Interaction J. Biol. Chem., November 8, 2002; 277(46): 44155 - 44163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Nemoto, H. Tada, and H. Shimauchi Disruption of CD40/CD40 ligand interaction with cleavage of CD40 on human gingival fibroblasts by human leukocyte elastase resulting in down-regulation of chemokine production J. Leukoc. Biol., September 1, 2002; 72(3): 538 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Challa, A. G. Eliopoulos, M. J. Holder, A. S. Burguete, J. D. Pound, A. Chamba, G. Grafton, R. J. Armitage, C. D. Gregory, H. Martinez-Valdez, et al. Population depletion activates autonomous CD154-dependent survival in biopsylike Burkitt lymphoma cells Blood, May 1, 2002; 99(9): 3411 - 3418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. S. Andersen, J. K. Larsen, J. Christiansen, L. B. Pedersen, N. S. Christophersen, C. H. Geisler, and J. Jurlander Soluble CD40 ligand induces selective proliferation of lymphoma cells in primary mantle cell lymphoma cell cultures Blood, September 15, 2000; 96(6): 2219 - 2225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Francisco, K. L. Donaldson, D. Chace, C. B. Siegall, and A. F. Wahl Agonistic Properties and in Vivo Antitumor Activity of the Anti-CD40 Antibody SGN-14 Cancer Res., June 1, 2000; 60(12): 3225 - 3231. [Abstract] [Full Text]
|
|